COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or “Company”) (CPH: BIOPOR) today announced that the KDIGO 2026 Clinical Practice Guideline Draft for Acute Kidney Injury (AKI) and Acute ...
HAYWARD, Calif., Sept. 13, 2022 /PRNewswire/ -- Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results